Fontolizumab in moderate to severe Crohnʼs disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study

Title
Fontolizumab in moderate to severe Crohnʼs disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume 16, Issue 2, Pages 233-242
Publisher
Oxford University Press (OUP)
Online
2009-07-28
DOI
10.1002/ibd.21038

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search